Comparative arrhythmia patterns among patients on tyrosine kinase inhibitors

被引：0
|
作者：
Chen Wei
Muhammad Fazal
Alexander Loh
Ridhima Kapoor
Sofia Elena Gomez
Shayena Shah
Albert J. Rogers
Sanjiv M. Narayan
Paul J. Wang
Ronald M. Witteles
Alexander C. Perino
Paul Cheng
June-Wha Rhee
Tina Baykaner
机构：
[1] Stanford University,Department of Internal Medicine
[2] Stanford University,Department of Cardiovascular Medicine
[3] Kaiser Permanente Santa Clara Homestead Medical Center,Department of Internal Medicine
[4] Stanford University,Stanford University School of Medicine
[5] City of Hope Comprehensive Medical Center,Division of Cardiology, Department of Medicine
来源：
Journal of Interventional Cardiac Electrophysiology | 2024年 / 67卷
关键词：
Cardio-oncology; Tyrosine kinase inhibitors; Ibrutinib; Arrhythmias; Atrial fibrillation; Tyrosine kinase inhibitors; Atrial arrhythmias; Ventricular arrhythmias;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：111 / 118
页数：7
相关论文
共 50 条
  • [1] Comparative arrhythmia patterns among patients on tyrosine kinase inhibitors
    Wei, Chen
    Fazal, Muhammad
    Loh, Alexander
    Kapoor, Ridhima
    Gomez, Sofia Elena
    Shah, Shayena
    Rogers, Albert J. J.
    Narayan, Sanjiv M. M.
    Wang, Paul J. J.
    Witteles, Ronald M. M.
    Perino, Alexander C. C.
    Cheng, Paul
    Rhee, June-Wha
    Baykaner, Tina
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2024, 67 (01) : 111 - 118
  • [2] Arrhythmia Patterns in Patients Managed With and Without Tyrosine Kinase Inhibitors
    Wei, Chen
    Fazal, Muhammad
    Kapoor, Ridhima
    Cheng, Paul
    Rogers, Albert J.
    Perino, Alexander C.
    Narayan, Sanjiv M.
    Rhee, June W.
    Baykaner, Tina
    CIRCULATION, 2022, 146
  • [3] Tyrosine kinase inhibitors, ionic currents, and cardiac arrhythmia
    Hu, Chi-Hao
    Wu, Sheng-Nan
    So, Edmund Cheung
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [4] Comparative QSAR study of tyrosine kinase inhibitors
    Kurup, A
    Garg, R
    Hansch, C
    CHEMICAL REVIEWS, 2001, 101 (08) : 2573 - 2600
  • [5] Risk ofQTcprolongation among cancer patients treated with tyrosine kinase inhibitors
    Abu Rmilah, Anan A.
    Lin, Grace
    Begna, Kebede H.
    Friedman, Paul A.
    Herrmann, Joerg
    INTERNATIONAL JOURNAL OF CANCER, 2020, 147 (11) : 3160 - 3167
  • [6] Assessment of Treatment Patterns and Adverse Events Among Patients with Chronic Myeloid Leukemia Using Tyrosine Kinase Inhibitors
    Karve, Sudeep
    Huang, Joanna C.
    Ranade, Nikhil
    Porwal, Sanchita
    Desai, Monali
    Rosenberg, Tanja
    BLOOD, 2018, 132
  • [7] Comparative Assessment of Echocardiographic Patterns Among Chronic Myeloid Leukemia Patients on Tyrosine Kinase Inhibitor and Healthy Controls
    Bamgboje, Abayomi O.
    Durosinmi, Muheez A.
    Mene-Afejuku, Tuoyo O.
    Fagbayimu, Micheal O.
    Fajobi, Olusola
    Balogun, Michael O.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2022, 18 : 27 - 42
  • [8] Comparison of Prescription Patterns of BCR-Abl Tyrosine Kinase Inhibitors Among Patients with Commercial Insurance, Medicare and Medicaid
    Kim, Myung Sun
    BLOOD, 2024, 144 : 7631 - 7632
  • [9] Comparative molecular field analysis of tyrosine kinase inhibitors
    Peng, T
    Pei, JF
    Zhou, JJ
    CHEMICAL JOURNAL OF CHINESE UNIVERSITIES-CHINESE, 2003, 24 (06): : 1076 - 1079
  • [10] Corneal perforations in patients on tyrosine kinase inhibitors
    Amar, J.
    El Kaim, P.
    Scemla, B.
    Boumendil, J.
    Chotard, G.
    Gabison, E.
    Bouheraoua, N.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2023, 46 (09): : 1111 - 1113
12345